| RS1553248947 |
CACNA1S
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1553249076 |
TPM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy 4B, autosomal recessive |
| RS1553249136 |
PBX1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1553249146 |
PBX1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1553249290 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553249294 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553249303 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553249311 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553249452 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553249704 |
NDUFS2
|
Health Risk |
Likely pathogenic |
Leber optic atrophy, Leber optic atrophy |
| RS1553249737 |
TMCO1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553250050 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553250072 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Retinitis pigmentosa 39 |
| RS1553250077 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553250150 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553250184 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553250192 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553250416 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553250627 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553250786 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553250952 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553251507 |
PRUNE1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553251644 |
TPM3
|
Health Risk |
Likely pathogenic |
Congenital myopathy with fiber type disproportion, Congenital myopathy 4B |
| RS1553251787 |
CD46
|
Health Risk |
Pathogenic/Likely pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS1553251903 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1553251907 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1553252041 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553252052 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553252343 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1553252363 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553252388 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1553252389 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553252409 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553252469 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553252475 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553252499 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553252528 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS1553252746 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1553252938 |
EMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cerebellar atrophy |
| RS1553253022 |
KIF14
|
Health Risk |
Pathogenic |
Microcephaly 20, primary |
| RS1553253747 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1553253812 |
PRUNE1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553253989 |
SLC25A24
|
Health Risk |
Pathogenic |
Fontaine progeroid syndrome, Fontaine progeroid syndrome |
| RS1553253990 |
SLC25A24
|
Health Risk |
Pathogenic |
Fontaine progeroid syndrome, Fontaine progeroid syndrome |
| RS1553254265 |
PRUNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1553254275 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1553254322 |
KIF14
|
Health Risk |
Likely pathogenic |
Microcephaly 20, primary |
| RS1553254475 |
COA7
|
Health Risk |
Likely pathogenic |
— |
| RS1553255288 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255293 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1553255301 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1553255312 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1553255354 |
ACTA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Actin accumulation myopathy |
| RS1553255357 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Progressive scapulohumeroperoneal distal myopathy |
| RS1553255360 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255361 |
ACTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Actin accumulation myopathy, Congenital myopathy 4A |
| RS1553255362 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 3, autosomal dominant or recessive |
| RS1553255432 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255444 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255446 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255479 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255482 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255486 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255501 |
ACTA1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553255502 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255506 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255521 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1553255534 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1553255775 |
SYT14
|
Health Risk |
Likely pathogenic |
— |
| RS1553256576 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553256587 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553257236 |
AP4B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 47, Hereditary spastic paraplegia 47 |
| RS1553257497 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553257498 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS1553257502 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS1553257685 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553257705 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553257707 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553257761 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553258031 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1553258037 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553258076 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553258097 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553258122 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553259060 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553259179 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553259191 |
AP4B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 47, Hereditary spastic paraplegia 47 |
| RS1553259463 |
AP4B1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Spastic paraplegia |
| RS1553259511 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259528 |
KIF14
|
Health Risk |
Pathogenic |
Microcephaly 20, primary |
| RS1553259529 |
MPZ
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553259536 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 1B |
| RS1553259539 |
KIF14
|
Health Risk |
Pathogenic |
Microcephaly 20, primary |
| RS1553259566 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259568 |
MPZ
|
Health Risk |
Pathogenic |
Dejerine-Sottas disease, Neuropathy |
| RS1553259602 |
PIGC
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 16, Glycosylphosphatidylinositol biosynthesis defect 16 |
| RS1553259614 |
PIGC
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 16, Glycosylphosphatidylinositol biosynthesis defect 16 |
| RS1553259643 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1553259647 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 1B |
| RS1553259648 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |